Company intelligence / Profile preview

Pontis Biologics, Inc.

Huntington, New York, United Statespontisbio.com ↗

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Pontis Biologics has developed a proprietary enzyme-based dentifrice, Tartarase™, designed to dissolve dental calculus. In a proof-of-principle randomized human clinical trial, the product demonstrated safety and efficacy in reducing existing dental tartar compared to standard toothpaste. The study showed that the Tartarase™ formulation could decrease calculus formation without adverse effects over four weeks.[4][5] The company is preparing for further human trials with recognized partners in dentistry.[2]

Therapeutic areas: Other
Modalities: Enzyme-based therapeutics (digestive enzymes in oral care)[5][6]
Industry: Non-Drug Biotech

Partnerships

Seeking partnerships with established healthcare/pharma companies for global distribution; no formal partnerships disclosed yet[2].

Beyond the preview

Go deeper on Pontis Biologics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pontis Biologics, Inc..